» Articles » PMID: 35849577

High Prevalence of Sexual Infection by Human Papillomavirus and Chlamydia Trachomatis in Sexually-active Women from a Large City in the Amazon Region of Brazil

Abstract

Background: The Human Papillomavirus (HPV) and Chlamydia trachomatis are the most prevalent Sexually Transmitted Infections (STIs) worldwide, and are associated cervical cancer and pelvic inflammatory disease, respectively. However, 80% of women testing positive are asymptomatic. In the Amazon region, young women, in particular, are widely exposed to the infections and their consequences.

Objectives: Determine the prevalence of sexual infection by HPV and C. trachomatis in young, sexually-active women treated at a university health program in a large city of the Brazilian Amazon region.

Methods: We amplified the L1 gene of HPV. We amplified ompA gene of C. trachomatis by nested PCR, and the study participants filled in a questionnaire on their social, epidemiological, and reproductive health characteristics. The data were analyzed using the Odds Ratio, to evaluate the degree of association of these variables with the observed infections.

Results: The prevalence of infection by HPV was 15.5% (47/303). This infection was recorded in 32.2% of the women of less than 25 years of age (OR:3.02 [CI95%] = 1.32-6.92; p = 0.014), 17.9% of the single women (OR: 2.41 [CI95%] = 1.22-4.75; p = 0.014), 23.8% of the women that reported having first sexual intercourse at less than 15 years of age (OR: 2.22 [CI95%] = 1.16-4.23; p = 0.021), 20% of those that reported having had more than one sexual partner during their lifetime (OR: 3.83 [CI95%] = 1.56-9.37; p = 0.003), and in 28.3% that use oral contraceptives (CI95% = 1.33-5.43; p = 0.008). The prevalence of sexual infection by C. trachomatis was 4.6% (14/303), and this bacterium was present in 16.1% of the young women of less than 25 years of age (OR: 2.86 [CI95%] = 1.33-5.43; p = 0.008).

Conclusions: We found a high prevalence of HPV in young, unmarried women who started their sex lives early, who had several sexual partners in their lives and who used oral contraceptives. The prevalence of C. trachomatis was high only in young women. Our data are in accordance with other studies in Brazil and in the world and may serve to base the formulation of diagnostic and screening measures for these infections in women in the Amazon.

Citing Articles

The Relationship Between Cervicovaginal Infection, Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia in Romanian Women.

Braila A, Poalelungi C, Albu C, Damian C, Dra L, Banateanu A Diseases. 2025; 13(1).

PMID: 39851482 PMC: 11764336. DOI: 10.3390/diseases13010018.


Distribution of High-Risk Human Papillomavirus in Self-Collected Cervicalvaginal Samples from the General Malian Population.

Kamate B, Kassogue Y, Diakite B, Traore B, Cisse K, Diarra F Biochem Genet. 2024; .

PMID: 39570507 DOI: 10.1007/s10528-024-10949-5.


Clinicopathological Findings and Comprehensive Review of Buschke-Lowenstein Tumors Based on a Case Study.

Grosu-Bularda A, Hariga C, Dumitru C, Calcaianu N, Creanga C, Enache V J Pers Med. 2024; 14(8).

PMID: 39202078 PMC: 11355402. DOI: 10.3390/jpm14080887.


Type-specific human papillomavirus prevalence in women referred for colposcopy in Tehran.

Soleimani-Jelodar R, Arashkia A, Shoja Z, Sharifian K, Akhavan S, Yarandi F Iran J Microbiol. 2024; 16(3):421-427.

PMID: 39005605 PMC: 11245344. DOI: 10.18502/ijm.v16i3.15799.


Prevalence and risk factors for high-risk human papillomavirus infection among women from three southern geopolitical zones of Nigeria.

Onwuamah C, Feng N, Momoh A, Uwandu M, Ahmed R, Idigbe I Front Oncol. 2023; 13:1254304.

PMID: 37876969 PMC: 10593479. DOI: 10.3389/fonc.2023.1254304.


References
1.
Guy R, Kong F, Goller J, Franklin N, Bergeri I, Dimech W . A new national Chlamydia Sentinel Surveillance System in Australia: evaluation of the first stage of implementation. Commun Dis Intell Q Rep. 2010; 34(3):319-28. View

2.
Rawre J, Juyal D, Dhawan B . Molecular typing of : An overview. Indian J Med Microbiol. 2017; 35(1):17-26. DOI: 10.4103/ijmm.IJMM_16_341. View

3.
Harden M, Munger K . Human papillomavirus molecular biology. Mutat Res Rev Mutat Res. 2017; 772:3-12. PMC: 5500221. DOI: 10.1016/j.mrrev.2016.07.002. View

4.
Colpani V, Soares Falcetta F, Bidinotto A, Kops N, Falavigna M, Hammes L . Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis. PLoS One. 2020; 15(2):e0229154. PMC: 7034815. DOI: 10.1371/journal.pone.0229154. View

5.
Teixeira J, Vale D, Braganca J, Campos C, Discacciati M, Zeferino L . Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol. BMC Public Health. 2020; 20(1):576. PMC: 7189449. DOI: 10.1186/s12889-020-08688-4. View